Clinical Trials
2 trialsNCT03038672 2026-05-12
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT03620578 2024-02-14
HO152
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2 Active not recruiting